Central America Investment Opportunities Pharmaceuticals: Risk/Reward Analysis

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether developed or emerging. BMI's Risk/Rewards Ratings (RRR) tool, which provides a globally comparative and numerically based assessment of a market's attractiveness, was established to address this. In BMI's Q413 RRRs, the Americas region scores 51 out of 100, compared to Western Europe (67), Central and Eastern Europe (52) Middle East and Africa (42) and Asia Pacific (53). ...

or Register now for free to download whitepaper

Access all of our latest analysis, data and forecasts - request a trial